Eli Lilly's experimental drug retatrutide helped Type 2 diabetes patients lose up to 16.8% of their body weight in a Phase 3 trial, topping all rivals ...

A new class of weight loss drug just took a major step toward approval for use. In a phase III clinical trial, medication ...

The next generation of weight loss drugs is already in trials. Lilly's retatrutide delivered nearly 17% weight loss in 40 weeks, with patients still losing weight at the end of the trial.

About 10 weeks after it was approved, the Wegovy pill is now estimated to be part of the daily regimen of about 400,000 Americans. And the field of weight-loss treatment is on the verge of even more ...

In the studies the company submitted to the FDA, people who took the daily Wegovy pill lost about the same amount of ...

In a study published in JAMA Network Open in January 2025, which included more than 125,000 patients, nearly 65 percent of ...

A GIP/GLP-1/glucagon triple agonist reduced HbA1c by up to 1.9 percentage points at 40 weeks for adults with type 2 diabetes, according to topline results from the TRANSCEND-T2D-1 trial. Retatrutide ...

For many Americans struggling to lose weight, powerful new medications are changing the game. With roughly 40% of U.S. adults living with obesity, according to the Centers for Disease Control ...

California is denying popular and effective weight loss drugs to poor people — likely to spite President Donald Trump, who has tried to make them cheaper. As a result, only those who can afford to pay ...

Did you know that prediabetes remission is possible without shedding the extra kgs? A recent research shows you don’t have to ...

While GLP-1 drugs can be effective for weight loss, they are not necessarily a permanent solution. Therefore, the duration of treatment can vary.

How to Help Your Partner Lose Weight This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. So, your partner has decided to lose weight, ...